49 results on '"Smit, Amelia"'
Search Results
2. Primary prevention of skin cancer in primary care settings
3. A review of skin cancer primary prevention activities in primary care settings
4. Acceptability and appropriateness of a risk-tailored organised melanoma screening program: Qualitative interviews with key informants
5. Unpacking factors contributing to melanoma overdiagnosis: does polygenic risk play a role?
6. A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies
7. Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia
8. Acceptability of risk-tailored cancer screening among Australian GPs: a qualitative study
9. Views of the Australian public on the delivery of risk-stratified cancer screening in the population: a qualitative study
10. Supplementary materials (clean version) from A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public
11. Personalised risk booklet - an example from A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public
12. Supplementary materials (clean version) from A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public
13. Personalised risk booklet - an example from A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public
14. Validation of self-reported sun exposure against electronic ultraviolet radiation dosimeters
15. Barriers and Facilitators for Population Genetic Screening in Healthy Populations: A Systematic Review
16. Precision Public Health Initiatives in Cancer: Proceedings from the Transdisciplinary Conference for Future Leaders in Precision Public Health
17. Using a Participatory Approach to Develop Research Priorities for Future Leaders in Cancer-Related Precision Public Health
18. Cost-effectiveness of targeted genomic risk provision to prevent skin cancer: Results of a randomized trial.
19. Using a Participatory Approach to Develop Research Priorities for Future Leaders in Precision Public Health
20. Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohorts*
21. Barriers and facilitators for population genetic screening in healthy populations: a systematic review
22. Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF)
23. Effect of an interactive educational activity using handheld ultraviolet radiation dosimeters on sun protection knowledge among Australian primary school students
24. Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial
25. 1036Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohorts
26. Knowledge, views and expectations for cancer polygenic risk testing in clinical practice: A cross‐sectional survey of health professionals
27. Advancing precision public health using human genomics: examples from the field and future research opportunities
28. Acceptability of risk‐stratified population screening across cancer types: Qualitative interviews with the Australian public
29. Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial
30. School-based interventions to improve sun-safe knowledge, attitudes and behaviors in childhood and adolescence: A systematic review
31. Family communication about genomic sequencing: A qualitative study with cancer patients and relatives
32. Can Patient-Led Surveillance Detect Subsequent New Primary or Recurrent Melanomas and Reduce the Need for Routinely Scheduled Follow Up? A Protocol for the MEL-SELF Randomised Controlled Trial.
33. Implementation considerations for offering personal genomic risk information to the public: a qualitative study
34. ‘There is a lot of good in knowing, but there is also a lot of downs’: public views on ethical considerations in population genomic screening
35. MC1R variants and associations with pigmentation characteristics and genetic ancestry in a Hispanic, predominately Puerto Rican, population
36. The Melanoma Genomics Managing Your Risk Study randomised controlled trial: Statistical Analysis Plan
37. Risk attitudes and sun protection behaviour: Can behaviour be altered by using a melanoma genomic risk intervention?
38. Patients’ Views About Skin Self-examination After Treatment for Localized Melanoma
39. GP attitudes to and expectations for providing personal genomic risk information to the public: a qualitative study
40. Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers
41. The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors
42. Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma
43. Validation of Questionnaire and Diary Measures of Time Outdoors Against an Objective Measure of Personal Ultraviolet Radiation Exposure
44. Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General Population
45. Abstract B15: Communicating information about personalised genomic risk of melanoma to family, friends, and health professionals
46. A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public
47. A pilot randomised controlled trial examining the feasibility, acceptability and impact of giving information on personalised genomic risk of melanoma to the public, for motivating preventive behaviours.
48. Public preferences for communicating personal genomic risk information: a focus group study
49. Exploring the Potential Emotional and Behavioural Impact of Providing Personalised Genomic Risk Information to the Public: A Focus Group Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.